Trial intelligence / Profile preview

Gayo Arabica Coffee Cascara Pulp Cream for Photoaging

NCT05390489Phase 1Completed

Start
Feb 2022
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of CognatiQ in photoaging. Primary endpoints: change in skin condition (irritation/redness) at 96 hours and change in Skin hydration at 96 hours. Started Feb 2022; status: completed.

02

Drugs

CognatiQ
03

Conditions

photoaging

Beyond the preview

Go deeper on NCT05390489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05390489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call